Antibody Drug Conjugates (ADCs) Market Report

Global and China Antibody Drug Conjugates (ADCs) Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 18, 2022
  • PAGES：139
  • REPORT CODE：GMM1384446
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds.  By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.  ADCs are part of a specialized subset of highly potent APIs.  This technically challenging type of therapy combines innovations from biotechnology and chemistry to form a new class of highly potent biopharmaceutical drugs.

    This report elaborates on the current development of the Antibody Drug Conjugates (ADCs) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Novartis

    • Kairos Therapeutics

    • Astellas Pharma

    • Genmab

    • AbGenomics

    • Pfizer

    • AbbVie

    • Seattle Genetics

    • Takeda Pharmaceuticals

    • Bayer

    • Roche

    • ADC Therapeutics

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Pfizer Technology

    • ImmunoGen Technology

    • Immunomedics Technology

    Application:

    • Hospital

    • Clinics

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Antibody Drug Conjugates (ADCs) Industry Overview

      • 1.1.1 Antibody Drug Conjugates (ADCs) Market Scope and Market Segments

      • 1.1.2 Antibody Drug Conjugates (ADCs) Industry Characteristics

      • 1.1.3 Global and China Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Antibody Drug Conjugates (ADCs) Production Value and Growth Rate (2017-2028)

    • 1.2 Global Antibody Drug Conjugates (ADCs) Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Pfizer Technology

      • 1.2.2 ImmunoGen Technology

      • 1.2.3 Immunomedics Technology

    • 1.3 Global Antibody Drug Conjugates (ADCs) Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Clinics

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Antibody Drug Conjugates (ADCs) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Antibody Drug Conjugates (ADCs) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Antibody Drug Conjugates (ADCs) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Antibody Drug Conjugates (ADCs) Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Antibody Drug Conjugates (ADCs) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Antibody Drug Conjugates (ADCs) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Antibody Drug Conjugates (ADCs) Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Antibody Drug Conjugates (ADCs) Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Antibody Drug Conjugates (ADCs) Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Antibody Drug Conjugates (ADCs) Industry Porter's Five Forces Model Analysis

      • 2.2.3 Antibody Drug Conjugates (ADCs) Industry PEST Analysis

    • 2.3 Antibody Drug Conjugates (ADCs) Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Antibody Drug Conjugates (ADCs) Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Antibody Drug Conjugates (ADCs) Industry

    Chapter 3 Global and China Antibody Drug Conjugates (ADCs) Market, by Manufacturer

    • 3.1 Global and China Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Antibody Drug Conjugates (ADCs) Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Antibody Drug Conjugates (ADCs) Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Antibody Drug Conjugates (ADCs) Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Antibody Drug Conjugates (ADCs) Market Top 3 Players

    Chapter 4 Global and China Antibody Drug Conjugates (ADCs) Market, by Type (2017-2028)

    • 4.1 Antibody Drug Conjugates (ADCs) Market Trend, by Type

    • 4.2 Global Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Antibody Drug Conjugates (ADCs) Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Antibody Drug Conjugates (ADCs) Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Antibody Drug Conjugates (ADCs) Price Trend, by Type (2017-2028)

    • 4.3 China Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Antibody Drug Conjugates (ADCs) Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Antibody Drug Conjugates (ADCs) Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Antibody Drug Conjugates (ADCs) Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Antibody Drug Conjugates (ADCs) Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Antibody Drug Conjugates (ADCs) Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Antibody Drug Conjugates (ADCs) Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Antibody Drug Conjugates (ADCs) Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Antibody Drug Conjugates (ADCs) Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Antibody Drug Conjugates (ADCs) Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Antibody Drug Conjugates (ADCs) Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Antibody Drug Conjugates (ADCs) Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Antibody Drug Conjugates (ADCs) Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Antibody Drug Conjugates (ADCs) Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Antibody Drug Conjugates (ADCs) Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Antibody Drug Conjugates (ADCs) Market Analysis

    • 7.1 North America Antibody Drug Conjugates (ADCs) Market, by Type

    • 7.2 North America Antibody Drug Conjugates (ADCs) Market, by Application

    • 7.3 North America Antibody Drug Conjugates (ADCs) Market Analysis and Forecast, by Country

      • 7.3.1 United States Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Antibody Drug Conjugates (ADCs) Market Analysis

    • 8.1 Europe Antibody Drug Conjugates (ADCs) Market, by Type

    • 8.2 Europe Antibody Drug Conjugates (ADCs) Market, by Application

    • 8.3 Europe Antibody Drug Conjugates (ADCs) Market Analysis and Forecast, by Country

      • 8.3.1 Germany Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Antibody Drug Conjugates (ADCs) Market Analysis

    • 9.1 APAC Antibody Drug Conjugates (ADCs) Market, by Type

    • 9.2 APAC Antibody Drug Conjugates (ADCs) Market, by Application

    • 9.3 APAC Antibody Drug Conjugates (ADCs) Market Analysis and Forecast, by Country

      • 9.3.1 China Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Antibody Drug Conjugates (ADCs) Market Analysis

    • 10.1 Latin America, Middle East and Africa Antibody Drug Conjugates (ADCs) Market, by Type

    • 10.2 Latin America, Middle East and Africa Antibody Drug Conjugates (ADCs) Market, by Application

    • 10.3 Latin America, Middle East and Africa Antibody Drug Conjugates (ADCs) Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Antibody Drug Conjugates (ADCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Antibody Drug Conjugates (ADCs) Company Profiles

      • 11.1 Novartis

        • 11.1.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Novartis Antibody Drug Conjugates (ADCs) Product Profiles, Application and Specification

        • 11.1.3 Novartis Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Kairos Therapeutics

        • 11.2.1 Kairos Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Kairos Therapeutics Antibody Drug Conjugates (ADCs) Product Profiles, Application and Specification

        • 11.2.3 Kairos Therapeutics Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Astellas Pharma

        • 11.3.1 Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Astellas Pharma Antibody Drug Conjugates (ADCs) Product Profiles, Application and Specification

        • 11.3.3 Astellas Pharma Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Genmab

        • 11.4.1 Genmab Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Genmab Antibody Drug Conjugates (ADCs) Product Profiles, Application and Specification

        • 11.4.3 Genmab Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 AbGenomics

        • 11.5.1 AbGenomics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 AbGenomics Antibody Drug Conjugates (ADCs) Product Profiles, Application and Specification

        • 11.5.3 AbGenomics Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Pfizer

        • 11.6.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Pfizer Antibody Drug Conjugates (ADCs) Product Profiles, Application and Specification

        • 11.6.3 Pfizer Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 AbbVie

        • 11.7.1 AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 AbbVie Antibody Drug Conjugates (ADCs) Product Profiles, Application and Specification

        • 11.7.3 AbbVie Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Seattle Genetics

        • 11.8.1 Seattle Genetics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Seattle Genetics Antibody Drug Conjugates (ADCs) Product Profiles, Application and Specification

        • 11.8.3 Seattle Genetics Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Takeda Pharmaceuticals

        • 11.9.1 Takeda Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Product Profiles, Application and Specification

        • 11.9.3 Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Bayer

        • 11.10.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Bayer Antibody Drug Conjugates (ADCs) Product Profiles, Application and Specification

        • 11.10.3 Bayer Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Roche

        • 11.11.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Roche Antibody Drug Conjugates (ADCs) Product Profiles, Application and Specification

        • 11.11.3 Roche Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 ADC Therapeutics

        • 11.12.1 ADC Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 ADC Therapeutics Antibody Drug Conjugates (ADCs) Product Profiles, Application and Specification

        • 11.12.3 ADC Therapeutics Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Antibody Drug Conjugates (ADCs) Industry Investment Prospect and Risk Assessment

    • 12.1 Antibody Drug Conjugates (ADCs) Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Antibody Drug Conjugates (ADCs) Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure China Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Global Antibody Drug Conjugates (ADCs) Production Value and Growth Rate (2017-2028)

    • Figure China Antibody Drug Conjugates (ADCs) Production Value and Growth Rate (2017-2028)

    • Figure Global Antibody Drug Conjugates (ADCs) Market Size and Growth Rate of Pfizer Technology (2017-2028)

    • Figure Global Antibody Drug Conjugates (ADCs) Market Size and Growth Rate of ImmunoGen Technology (2017-2028)

    • Figure Global Antibody Drug Conjugates (ADCs) Market Size and Growth Rate of Immunomedics Technology (2017-2028)

    • Figure Global Antibody Drug Conjugates (ADCs) Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Antibody Drug Conjugates (ADCs) Market Size and Growth Rate of Clinics (2017-2028)

    • Figure Global Antibody Drug Conjugates (ADCs) Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Antibody Drug Conjugates (ADCs) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Antibody Drug Conjugates (ADCs) Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Antibody Drug Conjugates (ADCs) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Antibody Drug Conjugates (ADCs) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Antibody Drug Conjugates (ADCs) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Antibody Drug Conjugates (ADCs) Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Antibody Drug Conjugates (ADCs) Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Antibody Drug Conjugates (ADCs) Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Antibody Drug Conjugates (ADCs) Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Antibody Drug Conjugates (ADCs) Market Share, by Manufacturer in 2021

    • Figure Global and China Antibody Drug Conjugates (ADCs) Market Share, by Manufacturer in 2022

    • Table Global Antibody Drug Conjugates (ADCs) Sales Volume, by Type (2017-2028)

    • Table Global Antibody Drug Conjugates (ADCs) Sales Volume Share, by Type (2017-2028)

    • Figure Global Antibody Drug Conjugates (ADCs) Sales Volume Share, by Type (2017-2028)

    • Table Global Antibody Drug Conjugates (ADCs) Sales Value, by Type (2017-2028)

    • Table Global Antibody Drug Conjugates (ADCs) Sales Value Share, by Type (2017-2028)

    • Figure Global Antibody Drug Conjugates (ADCs) Price Trend, by Type (2017-2028)

    • Table China Antibody Drug Conjugates (ADCs) Sales Volume, by Type (2017-2028)

    • Table China Antibody Drug Conjugates (ADCs) Sales Volume Share, by Type (2017-2028)

    • Figure China Antibody Drug Conjugates (ADCs) Sales Volume Share, by Type (2017-2028)

    • Table China Antibody Drug Conjugates (ADCs) Sales Value, by Type (2017-2028)

    • Table China Antibody Drug Conjugates (ADCs) Sales Value Share, by Type (2017-2028)

    • Figure China Antibody Drug Conjugates (ADCs) Price Trend, by Type (2017-2028)

    • Table Global Antibody Drug Conjugates (ADCs) Sales Volume, by Application (2017-2028)

    • Table Global Antibody Drug Conjugates (ADCs) Sales Volume Share, by Application (2017-2028)

    • Figure Global Antibody Drug Conjugates (ADCs) Sales Volume Share, by Application (2017-2028)

    • Table Global Antibody Drug Conjugates (ADCs) Sales Value, by Application (2017-2028)

    • Table Global Antibody Drug Conjugates (ADCs) Sales Value Share, by Application (2017-2028)

    • Figure Global Antibody Drug Conjugates (ADCs) Sales Value Share, by Application (2017-2028)

    • Table China Antibody Drug Conjugates (ADCs) Sales Volume, by Application (2017-2028)

    • Table China Antibody Drug Conjugates (ADCs) Sales Volume Share, by Application (2017-2028)

    • Figure China Antibody Drug Conjugates (ADCs) Sales Volume Share, by Application (2017-2028)

    • Table China Antibody Drug Conjugates (ADCs) Sales Value, by Application (2017-2028)

    • Table China Antibody Drug Conjugates (ADCs) Sales Value Share, by Application (2017-2028)

    • Figure China Antibody Drug Conjugates (ADCs) Sales Value Share, by Application (2017-2028)

    • Figure China Antibody Drug Conjugates (ADCs) Production, Import, Consumption and Export (2017-2022)

    • Figure North America Antibody Drug Conjugates (ADCs) Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Antibody Drug Conjugates (ADCs) Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Antibody Drug Conjugates (ADCs) Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Antibody Drug Conjugates (ADCs) Production, Import, Consumption and Export (2017-2022)

    • Table North America Antibody Drug Conjugates (ADCs) Sales Volume, by Type (2017-2028)

    • Table North America Antibody Drug Conjugates (ADCs) Sales Volume Share, by Type (2017-2028)

    • Figure North America Antibody Drug Conjugates (ADCs) Sales Volume Share, by Type (2017-2028)

    • Table North America Antibody Drug Conjugates (ADCs) Sales Volume, by Application (2017-2028)

    • Table North America Antibody Drug Conjugates (ADCs) Sales Volume Share, by Application (2017-2028)

    • Figure North America Antibody Drug Conjugates (ADCs) Sales Volume Share, by Application (2017-2028)

    • Figure United States Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure United States Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Figure Canada Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Table Europe Antibody Drug Conjugates (ADCs) Sales Volume, by Type (2017-2028)

    • Table Europe Antibody Drug Conjugates (ADCs) Sales Volume Share, by Type (2017-2028)

    • Figure Europe Antibody Drug Conjugates (ADCs) Sales Volume Share, by Type (2017-2028)

    • Table Europe Antibody Drug Conjugates (ADCs) Sales Volume, by Application (2017-2028)

    • Table Europe Antibody Drug Conjugates (ADCs) Sales Volume Share, by Application (2017-2028)

    • Figure Europe Antibody Drug Conjugates (ADCs) Sales Volume Share, by Application (2017-2028)

    • Figure Germany Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Figure UK Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure UK Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Figure France Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure France Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Figure Italy Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Figure Spain Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Figure Poland Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Figure Russia Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Table APAC Antibody Drug Conjugates (ADCs) Sales Volume, by Type (2017-2028)

    • Table APAC Antibody Drug Conjugates (ADCs) Sales Volume Share, by Type (2017-2028)

    • Figure APAC Antibody Drug Conjugates (ADCs) Sales Volume Share, by Type (2017-2028)

    • Table APAC Antibody Drug Conjugates (ADCs) Sales Volume, by Application (2017-2028)

    • Table APAC Antibody Drug Conjugates (ADCs) Sales Volume Share, by Application (2017-2028)

    • Figure APAC Antibody Drug Conjugates (ADCs) Sales Volume Share, by Application (2017-2028)

    • Figure China Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure China Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Figure Japan Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Figure India Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure India Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Antibody Drug Conjugates (ADCs) Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Antibody Drug Conjugates (ADCs) Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Antibody Drug Conjugates (ADCs) Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Antibody Drug Conjugates (ADCs) Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Antibody Drug Conjugates (ADCs) Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Antibody Drug Conjugates (ADCs) Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Antibody Drug Conjugates (ADCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Antibody Drug Conjugates (ADCs) Sales Value and Growth Rate (2017-2028)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Kairos Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Kairos Therapeutics Product Profiles, Application and Specification

    • Table Kairos Therapeutics Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma Product Profiles, Application and Specification

    • Table Astellas Pharma Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Genmab Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Genmab Product Profiles, Application and Specification

    • Table Genmab Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AbGenomics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AbGenomics Product Profiles, Application and Specification

    • Table AbGenomics Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AbbVie Product Profiles, Application and Specification

    • Table AbbVie Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Seattle Genetics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Seattle Genetics Product Profiles, Application and Specification

    • Table Seattle Genetics Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Takeda Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Takeda Pharmaceuticals Product Profiles, Application and Specification

    • Table Takeda Pharmaceuticals Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer Product Profiles, Application and Specification

    • Table Bayer Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table ADC Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table ADC Therapeutics Product Profiles, Application and Specification

    • Table ADC Therapeutics Antibody Drug Conjugates (ADCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US